Show simple item record

dc.contributor.authorGuantai, Eric M.
dc.contributor.authorNcokazi, kanyile
dc.contributor.authorEgan, Timonthy J.
dc.contributor.authorGut, Jiri
dc.contributor.authorRosenthal, Philip J.
dc.contributor.authorSmith, peter J.
dc.contributor.authorChibale, Kelly
dc.date.accessioned2013-04-22T13:46:47Z
dc.date.available2013-04-22T13:46:47Z
dc.date.issued2010-12
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S0968089610009193
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16512
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/21044845
dc.description.abstractA targeted series of chalcone and dienone hybrid compounds containing aminoquinoline and nucleoside templates was synthesized and evaluated for in vitro antimalarial activity. The Cu(I)-catalyzed cycloaddition of azides and terminal alkynes was applied as the hybridization strategy. Several chalcone-chloroquinoline hybrid compounds were found to be notably active, with compound 8b the most active, exhibiting submicromolar IC50 values against the D10, Dd2 and W2 strains of Plasmodium falciparumen
dc.language.isoenen
dc.relation.ispartofseriesVol.18, Issue 23, Pages 8243–8256 2010;
dc.titleDesign, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compoundsen
dc.typeArticleen
local.publisherDepartment of Medicine. College of Health Sciences. University of Nairobien


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record